Detailed Studies and Analyses Sample Clauses

Detailed Studies and Analyses. Based on the work performed in Section 4.04, the Consultant will determine whether detailed analysis or study is required. Prior to commencing such detailed study or analysis, the Sponsor must concur with the Consultant’s determination. Detailed study or analysis work will be performed and documented as detailed in the LPM Manual, as well as in the PDM and the TEM. Results of the detailed study or analysis will be summarized in the appropriate section of the DAD.
Sample 1Sample 2
AutoNDA by SimpleDocs
Detailed Studies and Analyses. Based on the work performed in Section 4.03, the Consultant will determine whether detailed analysis or study is required. Prior to commencing such detailed study or analysis, the Sponsor must concur with the Consultant’s determination. Detailed study or analysis work will be performed and documented as detailed in the LPM, as well as in the PDM and the TEM. Results of the detailed study or analysis will be summarized in the appropriate section of the DAD. Detailed study or analysis will be done for: A. General Ecology and Endangered Species B. Ground Water C. Surface Water D. State Wetlands E. Federal Wetlands F. Floodplains G. Coastal Zone Management H. Historic Resources and/or Archaeological Resources X. Xxxxx - Section 4(f) and Section 6(f) Evaluations J. Hazardous Waste
Sample 1
Detailed Studies and Analyses. Based on the work performed in Section 4.04, the Consultant will determine whether detailed analysis or study is required. Prior to commencing such detailed study or analysis, the Sponsor must concur with the Consultant’s determination. Detailed study or analysis work will be performed and documented as detailed in the PLAFAP Manual, as well as in the PDM and the TEM. Results of the detailed study or analysis will be summarized in the appropriate section of the DAD. It is assumed a detailed study or analysis will be done for: A. General Ecology and Endangered Species B. Historic Resources
Sample 1
Detailed Studies and Analyses. The results of these detailed studies and analyses will be summarized in the appropriate sections of the DAD. - General Ecology and Endangered Species Assume no detailed study is required for endangered and threatened species. - Ground Water Assume no detailed study is required for groundwater. The project is not located within a NYSDEC Aquifer area. The project will NOT result in new highway construction, significant pavement widening, or the construction of additional travel lanes. As a result, it is assumed that a Xxxxx Analysis or FHWA Pollutant Loadings and Impacts from Highway Stormwater Runoff, 1990 is not required. - Surface Water Assume no detailed study is required for surface water. - State Wetlands There are no mapped state wetlands within the anticipated project limits. However, assume that state regulated wetlands will be considered as part of the wetlands screening. Assume no detailed study is required for state wetlands. - Federal Wetlands There are no mapped federal wetlands within the anticipated project limits. Assume no detailed study is required for federal wetlands. - Wetland Map and Delineation Report Assume a wetlands delineation report will be required. Assume minor wetland areas will be identified within the project area.
Sample 1
Detailed Studies and Analyses. Based on the work performed in Section 4.03, the Consultant will determine whether a detailed analysis or study is required. Prior to commencing such a detailed study or analysis, the Sponsor must concur with the Consultant’s determination. Detailed study or analysis work will be performed and documented as detailed in the NYSDOT LPM, as well as in the PDM and the TEM. Results of the detailed study or analysis will be summarized in the appropriate section of the DAD. Detailed study or analysis will be done for: A. General Ecology and Endangered Species (NOT IN AGREEMENT) B. Ground Water (NOT IN AGREEMENT) C. Surface Water (NOT IN AGREEMENT) D. State Wetlands (NOT IN AGREEMENT) E. Federal Wetlands (NOT IN AGREEMENT) F. Floodplains (NOT IN AGREEMENT)
Sample 1
Detailed Studies and Analyses. Based on the work performed in Section 4.03, the Consultant will determine whether detailed analysis or study is required. Prior to commencing such detailed study or analysis, the Municipality must concur with the Consultant’s determination and a supplemental agreement executed prior to any work being initiated under this task. Detailed study or analysis work will be performed and documented as detailed in the NYSDOT Locally Administered Federal Aid Procedures Manual. Results of the detailed study or analysis will be summarized in the appropriate section of the DAD. Detailed study or analysis will be done for: A. General Ecology and Endangered Species B. Ground Water C. Surface Water D. State Wetlands E. Federal Wetlands F. Floodplains G. Coastal Zone Management H. Historic Resources X. Xxxxx - Section 4(f) and Section 6(f) Evaluations X. Xxxxxxxxx Waste
Sample 1
Detailed Studies and Analyses. Based on the work performed in Section 4.04, the Consultant will determine whether detailed analysis or study is required. Prior to commencing such detailed study or analysis, the Sponsor must concur with the Consultant’s determination. Detailed study or analysis work will be performed and documented as detailed in the LPM Manual, as well as in the PDM and the TEM. Results of the detailed study or analysis will be summarized in the appropriate section of the DAD. Detailed study or analysis will be done for: • General Ecology and Endangered Species • Ground Water • Surface Water • State Wetlands • Federal Jurisdictional Wetlands • Floodplains • Coastal Zone Management • Navigable Waterways • Historic Resources • Parks • Hazardous Waste • Asbestos • Noise • Air Quality • Energy • Farmlands • Invasive Species • Visual Impacts • Critical Environmental Areas • Smart Growth • Environmental Justice
Sample 1
AutoNDA by SimpleDocs

Related to Detailed Studies and Analyses

  • Development Reports Beginning six months after Effective Date and ending on the date of first commercial sale of a Licensed Product in the United States, LICENSEE shall report to Cornell progress covering LICENSEE's (and Affiliate's and Sublicensee's) activities and efforts in the development of rights granted to LICENSEE under this Agreement for the preceding six months. The report shall include, but not be limited to, activities and efforts to develop and test all Licensed Products and obtain governmental approvals necessary for marketing the same. Such semi-annual reports shall be due within sixty days (60) of the reporting period and shall use the form as provided herein as Appendix C.

  • Studies The clinical, pre-clinical and other studies and tests conducted by or on behalf of or sponsored by the Company or its subsidiaries that are described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus were and, if still pending, are being conducted in accordance in all material respects with all statutes, laws, rules and regulations, as applicable (including, without limitation, those administered by the FDA or by any foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA). The descriptions of the results of such studies and tests that are described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus are accurate and complete in all material respects and fairly present the published data derived from such studies and tests, and each of the Company and its subsidiaries has no knowledge of other studies or tests the results of which are materially inconsistent with or otherwise call into question the results described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, neither the Company nor its subsidiaries has received any notices or other correspondence from the FDA or any other foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA with respect to any ongoing clinical or pre-clinical studies or tests requiring the termination or suspension of such studies or tests. For the avoidance of doubt, the Company makes no representation or warranty that the results of any studies, tests or preclinical or clinical trials conducted by or on behalf of the Company will be sufficient to obtain governmental approval from the FDA or any foreign, state or local governmental body exercising comparable authority.

  • Commercialization Reports Throughout the term of this Agreement and during the Sell-Off Period, and within thirty (30) days of December 31st of each year, Company will deliver to University written reports of Company’s and Sublicensees’ efforts and plans to develop and commercialize the innovations covered by the Licensed Rights and to make and sell Licensed Products. Company will have no obligation to prepare commercialization reports in years where (a) Company delivers to University a written Sales Report with active sales, and (b) Company has fulfilled all Performance Milestones. In relation to each of the Performance Milestones each commercialization report will include sufficient information to demonstrate achievement of those Performance Milestones and will set out timeframes and plans for achieving those Performance Milestones which have not yet been met.

  • Studies and Reports All copies in the Seller’s possession of studies and/or reports which have previously been performed in connection with or for the Property, including without limitation, environmental reports, soils studies, seismic studies, physical inspection reports, site plans and surveys, and identification of such studies of which the Seller is aware but that are not in their possession;

  • Budgets, Forecasts, Other Reports and Information Promptly upon their becoming available to the Borrower: (i) any reports, notices or proxy statements generally distributed by the Borrower to its stockholders on a date no later than the date supplied to such stockholders, (ii) regular or periodic reports, including Forms 10-K, 10-Q and 8-K, registration statements and prospectuses, filed by the Borrower with the SEC, (iii) to the extent not previously reported in regular or periodic reports, including Forms 10-K, 10-Q and 8-K, registration statements and prospectuses, filed by the Borrower with the SEC, the Borrower shall notify the Banks promptly of the enactment or adoption of any Law which may result in a Material Adverse Change, (iv) to the extent requested by the Agent or any Bank, the annual budget and any forecasts or projections of the Loan Parties, and (v) with respect to the Hedging Transaction activities of the Loan Parties and their Subsidiaries, to the extent not previously reported in regular or periodic reports, including Forms 10-K, 10-Q and 8-K, registration statements and prospectuses, filed by the Borrower with the SEC, such other reports and information as any of the Banks may from time to time reasonably request.

  • Right to Review Tax Returns Upon request, each party shall make available to the other party the portion of Pre-Separation Period Tax Returns that relates to the ALC Group that the first party is responsible for preparing under this Article III.

  • Inspection of Properties and Books Etc The Borrower shall permit the Lenders, through the Administrative Agent or any of the Lenders’ other designated representatives, no more frequently than once each calendar year, or more frequently as determined by the Lenders upon the occurrence and during the continuance of an Event of Default, to visit and inspect any of the properties of the Borrower or any of its Subsidiaries, and each such inspection, if no Event of Default has occurred and is continuing, shall be at the Lenders’ expense. The Borrower shall also permit the Lenders, through the Administrative Agent or any of the Lenders’ other designated representatives, to examine the books of account of the Borrower and its Subsidiaries (and to make copies thereof and extracts therefrom), and to discuss the affairs, finances and accounts of the Borrower and its Subsidiaries with, and to be advised as to the same by, its and their officers, all at such reasonable times and intervals as the Administrative Agent or any Lender may reasonably request. The Borrower authorizes the Administrative Agent and, if accompanied by the Administrative Agent, the Lenders to communicate directly with the Borrower’s independent certified public accountants and authorizes such accountants to disclose to the Administrative Agent and the Lenders any and all financial statements and other supporting financial documents and schedules with respect to the business, financial condition and other affairs of the Borrower or any of its Subsidiaries.

  • Special Analyses It is hereby certified that these regulations will not have a significant economic impact on a substantial number of small entities. This certification is based on the fact that it is unlikely that a substantial number of small entities will hold REMIC residual interests. Therefore, a Regulatory Flexibility Analysis under the Regulatory Flexibility Act (5 U.S.C. chapter 6) is not required. It has been determined that this Treasury decision is not a significant regulatory action as defined in Executive Order 12866. Therefore, a regulatory assessment is not required. It also has been determined that sections 553(b) and 553(d) of the Administrative Procedure Act (5 U.S.C. chapter 5) do not apply to these regulations. The principal author of these regulations is Xxxxxxxx Xxxxxxxxxx. However, other personnel from the IRS and Treasury Department participated in their development. 26 CFR Part 1 Income taxes, Reporting and record keeping requirements.

  • Investment Analysis and Commentary The Subadviser will provide quarterly performance analysis and market commentary (the “Investment Report”) during the term of this Agreement. The Investment Reports are due within 10 days after the end of each quarter. In addition, interim Investment Reports shall be issued at such times as may be mutually agreed upon by the Adviser and Subadviser; provided however, that any such interim Investment Report will be due within 10 days of the end of the month in which such agreement is reached between the Adviser and Subadviser. The subject of each Investment Report shall be mutually agreed upon. The Adviser is freely able to publicly distribute the Investment Report.

  • Inspection of Properties and Books The Borrower and the Guarantors will, and will cause their respective Subsidiaries to, permit the Agent and the Lenders, at the Borrower’s expense (to the extent provided for below) and upon reasonable prior notice, to visit and inspect any of the properties of the Borrower, each Guarantor or any of their respective Subsidiaries (subject to the rights of tenants under their Leases), to examine the books of account of the Borrower, any Guarantor and their respective Subsidiaries (and to make copies thereof and extracts therefrom) and to discuss the affairs, finances and accounts of the Borrower, any Guarantor and their respective Subsidiaries with, and to be advised as to the same by, their respective officers, partners or members, all at such reasonable times and intervals as the Agent or any Lender may reasonably request, provided that so long as no Default or Event of Default shall have occurred and be continuing, the Borrower shall not be required to pay for such visits and inspections more often than once in any twelve (12) month period. The Lenders shall use good faith efforts to coordinate such visits and inspections so as to minimize the interference with and disruption to the normal business operations of such Persons.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!